Investors grab European equities to gain cheap US exposure
Investors seeking returns from the buoyant American market are turning to European stocks which have significant US exposure ...
3 Reasons to Buy BioAge Labs Stock Hand Over Fist in October
3 Reasons to Buy BioAge Labs Stock Hand Over Fist in October was originally published by The Motley Fool ...
Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades
And what better place to find dominant companies with decades-long growth opportunities than in healthcare? Healthcare isn't going anywhere, and it's already a multitrillion-dollar industry in America ...
Weight-Loss Drugs Are Everywhere Now. How the GLP-1 Copycats Took Over.
Wegovy and Zepbound are still hard to get. Knockoff versions from Noom, Ro, and others are filing in the gaps.
End of Zepbound Shortage Threatens $1 Billion Knockoff Weight-Loss Shot Industry
Americans who turned to telehealth companies and compounding pharmacies for cheap versions of Eli Lilly & Co.’s weight-loss ...
Eli Lilly & Co. stock rises Friday, still underperforms market
Eli Lilly & Co. closed $85.37 below its 52-week high ($972.53), which the company reached on August 22nd.